OncoArendi Therapeutics SA (1B1) Q2 2026 Earnings Report
DE:1B1 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.02
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.04
DE:1B1 Q2 2026 Revenue Results
- Actual Revenue
- EUR 35.33K
- Expected Revenue
- EUR 259.99K
- Beat/Miss
- Missed by -EUR 224.66K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 09/30/2026
- Time
- TBA
- Conference Call
- Wednesday, September 30, 2026
DE:1B1 Upcoming Earnings
OncoArendi Therapeutics SA's next earnings date is estimated for April 6, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1B1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 06, 2027 | 2026 (Q4) | ―- | -0.02 | ― | ― |
| Oct 30, 2026 | 2026 (Q3) | ―- | -0.06 | ― | |
| Sep 30, 2026 | 2026 (Q2) | ―-0.02 | -0.04 | 43.53% (+0.02) | |
| Apr 30, 2026 | 2026 (Q1) | ―- | -0.06 | ― | |
| Mar 31, 2026 | 2025 (Q4) | ―-0.02 | -0.12 | 83.78% (+0.10) | |
| Oct 31, 2025 | 2025 (Q3) | ―- | -0.08 | ― | |
| Sep 30, 2025 | 2025 (Q2) | ―-0.04 | -0.1 | 62.96% (+0.07) | |
| Apr 30, 2025 | 2025 (Q1) | ―- | -0.09 | ― | |
| Mar 31, 2025 | 2024 (Q4) | ―-0.12 | -0.23 | 48.30% (+0.11) | |
| Oct 15, 2024 | 2024 (Q3) | ―-0.08 | -0.06 | -48.80% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
